Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Liver resection in hepatocellular carcinoma]

W Lauchart1, M J Sessler, R Viebahn

  • 1Chirurgische Klinik und Poliklinik, Abteilung für Allgemeine Chirurgie, Eberhard-Karls-Universität Tübingen.

Zentralblatt Fur Chirurgie
|January 1, 1994
PubMed
Summary

Hepatic resection is the only cure for hepatocellular carcinoma. Treatment depends on tumor stage and liver function, with multimodal options for unresectable cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Popliteal endarterectomy at the leg level with venous enlargement patch: about 14 cases.

Journal of surgical case reports·2023
Same author

Consensus on definition and severity grading of lymphatic complications after kidney transplantation.

The British journal of surgery·2020
Same author

[Primary treatment of anal cancer].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2018
Same author

Encapsulation of Islets in Rough Surface, Hydroxymethylated Polysulfone Capillaries Stimulates VEGF Release and Promotes Vascularization after Transplantation.

Cell transplantation·2017
Same author

Successful Simultaneous Pancreas-Kidney Re-transplantation in a Highly Human Leukocyte Antigen-Sensitized Patient.

Transplantation proceedings·2017
Same author

Predicting quality of deceased donor kidneys: the harvesting surgeon as a prognostic factor?

Transplantation proceedings·2013

Area of Science:

  • Hepatobiliary Surgery
  • Surgical Oncology
  • Medical Imaging

Context:

  • Hepatocellular carcinoma (HCC) management relies on accurate preoperative tumor staging.
  • Hepatic function significantly influences surgical resectability and treatment options.
  • Tumor characteristics like size, focality, encapsulation, and vascular invasion impact prognosis.

Purpose:

  • To outline current strategies for managing hepatocellular carcinoma based on tumor staging and hepatic function.
  • To detail criteria for surgical resection versus palliative or multimodal interventions.
  • To highlight the role of adjuvant therapies and multimodality treatment protocols.

Summary:

  • Hepatic resection provides the sole curative option for hepatocellular carcinoma (HCC).

Related Experiment Videos

  • Preoperative staging utilizes imaging (ultrasound, CT, MRI) to assess resectability, which is limited by compromised liver function.
  • Unfavorable prognostic factors (large diameter, multifocality, nonencapsulation, vascular invasion) necessitate combined adjuvant chemotherapy/chemoembolization with surgery.
  • For irresectable HCC, multimodality treatments including intravenous chemotherapy and radio-immunotherapy are increasingly employed.

    • Impact:

    • Optimizing treatment selection for hepatocellular carcinoma patients.
    • Improving outcomes through tailored surgical and adjuvant therapeutic approaches.
    • Advancing the management of both resectable and irresectable liver cancer cases.